Reduced hypoglycemia (d = 0.47‐0.79), reduced basal insulin requirements (d = 0.48), and a smaller glucose coefficient of variation (d = 0.47) occurred with medium-large effect sizes from baseline to 9 months. Here, INS is linked to Hypoglycemia.